Stem Cell Reports Impact Factor, Indexing, Ranking 2024

Stem Cell Reports is an open access forum communicating basic discoveries in stem cell research, in addition to translational and clinical studies. Stem Cell Reports focuses on manuscripts that report original research with conceptual or practical advances that are of broad interest to stem cell biologists and clinicians.Given the rapidly increasing impact of stem cell research to regenerative medicine and tissue engineering, Stem Cell Reports encourages the submission of manuscripts whose scope bridges these fields of research. The journal also encourages the submission of reports of robust new methodologies with biological significance and/or the potential to advance the application of basic research from the laboratory to the clinic. Stem Cell Reports promotes transparency in stem cell research and related fields of research through the publication of confirmatory findings, negative results, and adverse events.Stem Cell Reports covers: Embryonic stem cells Adult stem cells Reprogramming to pluripotency and lineage conversion Directed differentiation Germ cells Genetic and epigenetic mechanisms Stem cells in development Stem cell niche Cancer stem cells Disease modeling and drug screening Stem cell therapy Clinical studies in regenerative medicine Tissue engineering and biomaterials Imaging and diagnostics Stem cell products, manufacturing, and quality control Ethical, legal, and social issues

干细胞报告（Stem Cell Reports）系一本开放获取的学术论坛，旨在交流干细胞研究领域的基石性发现，以及转化和临床研究。该期刊专注于发表具有概念或实践创新，并对干细胞生物学家和临床医生具有广泛兴趣的原创研究成果。鉴于干细胞研究在再生医学和组织工程领域影响之迅速增长，干细胞报告期刊鼓励提交跨足这些研究领域的研究论文。期刊还鼓励提交具有生物学意义及/或能够推动基础研究从实验室到临床应用的新方法论报告。干细胞报告期刊通过发表验证性发现、阴性结果及不良事件，促进干细胞研究及相关领域研究的透明度。该期刊涵盖以下内容：胚胎干细胞、成年干细胞、重编程至多能性和谱系转换、定向分化、生殖细胞、遗传和表观遗传机制、发育中的干细胞、干细胞微环境、癌症干细胞、疾病建模和药物筛选、干细胞治疗、再生医学临床研究、组织工程和生物材料、成像和诊断、干细胞产品、制造和质量控制、伦理、法律和社会问题。